Banking and financial services
White collar crime
Michael’s practice focuses on regulatory and financial investigations by U.S. law enforcement agencies, such as the U.S. Department of Justice, U.S. Attorneys’ Offices, the Federal Bureau of Investigation, and the Internal Revenue Service; U.S. regulatory agencies, including the Public Company Accounting Oversight Board, the Securities and Exchange Commission, the Food & Drug Administration, and the Commodity Futures Trading Commission; as well as congressional subcommittees.
Michael has considerable experience representing accounting firms in regulatory and congressional investigations, as well as securities litigation. He has represented firms on three continents in U.S. and cross-border regulatory investigations, quietly resolving more than two dozen SEC, PCAOB and CFTC investigations with no enforcement action. Michael also represents life science companies in investigations of antikickback, off-label promotion and false claims matters. He recently served as lead trial counsel for Vascular Solutions, Inc., a publicly traded medical device company, in a groundbreaking federal criminal trial involving off-label promotion charges. After a five-year investigation and a three-week trial, the Texas jury acquitted the company and its CEO of all charges.
Last updated Sep 2020